Oates JC - Search Results

1

Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus.

Xu L, Zhao J, Sun Q, Xu X, Wang L, Liu T, Wu Y, Zhu J, Geng L, Deng Y, Awgulewitsch A, Kamen DL, Oates JC, Raj P, Wakeland EK, Scofield RH, Guthridge JM, James JA, Hahn BH, McCurdy DK, Wang F, Zhang M, Tan W, Gilkeson GS, Tsao BP. Xu L, et al. Among authors: oates jc. Ann Rheum Dis. 2022 Dec;81(12):1712-1721. doi: 10.1136/ard-2022-222795. Epub 2022 Aug 17. Ann Rheum Dis. 2022. PMID: 35977808 Free PMC article.

2

Effect of late modulation of nitric oxide production on murine lupus.

Oates JC, Ruiz P, Alexander A, Pippen AM, Gilkeson GS. Oates JC, et al. Clin Immunol Immunopathol. 1997 Apr;83(1):86-92. doi: 10.1006/clin.1997.4332. Clin Immunol Immunopathol. 1997. PMID: 9073540 Free PMC article.

3

Correlation of serum measures of nitric oxide production with lupus disease activity.

Gilkeson G, Cannon C, Oates J, Reilly C, Goldman D, Petri M. Gilkeson G, et al. J Rheumatol. 1999 Feb;26(2):318-24. J Rheumatol. 1999. PMID: 9972965

4

Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity.

Oates JC, Christensen EF, Reilly CM, Self SE, Gilkeson GS. Oates JC, et al. Proc Assoc Am Physicians. 1999 Nov-Dec;111(6):611-21. doi: 10.1046/j.1525-1381.1999.99110.x. Proc Assoc Am Physicians. 1999. PMID: 10591091

5

Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists.

Reilly CM, Oates JC, Cook JA, Morrow JD, Halushka PV, Gilkeson GS. Reilly CM, et al. Among authors: oates jc. J Immunol. 2000 Feb 1;164(3):1498-504. doi: 10.4049/jimmunol.164.3.1498. J Immunol. 2000. PMID: 10640767

6

Prostaglandin J(2) inhibition of mesangial cell iNOS expression.

Reilly CM, Oates JC, Sudian J, Crosby MB, Halushka PV, Gilkeson GS. Reilly CM, et al. Among authors: oates jc. Clin Immunol. 2001 Mar;98(3):337-45. doi: 10.1006/clim.2000.4985. Clin Immunol. 2001. PMID: 11237557

7

Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases.

Oates JC, Reilly CM, Crosby MB, Gilkeson GS. Oates JC, et al. Arthritis Rheum. 2002 Mar;46(3):598-605. doi: 10.1002/art.10052. Arthritis Rheum. 2002. PMID: 11920394 Free article. Review. No abstract available.

8

Mediators of injury in lupus nephritis.

Oates JC, Gilkeson GS. Oates JC, et al. Curr Opin Rheumatol. 2002 Sep;14(5):498-503. doi: 10.1097/00002281-200209000-00003. Curr Opin Rheumatol. 2002. PMID: 12192244 Review.

9

Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans.

Oates JC, Levesque MC, Hobbs MR, Smith EG, Molano ID, Page GP, Hill BS, Weinberg JB, Cooper GS, Gilkeson GS. Oates JC, et al. J Rheumatol. 2003 Jan;30(1):60-7. J Rheumatol. 2003. PMID: 12508391

10

Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice.

Oates JC, Gilkeson GS. Oates JC, et al. J Investig Med. 2004 Jan;52(1):62-71. doi: 10.1136/jim-52-01-29. J Investig Med. 2004. PMID: 14989372 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters